RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro® XV Diagnostic ...
RIVANNA receives US FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound imaging system
RIVANNA receives US FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound imaging system: Charlottesville, Virginia Saturday, May 9, 2026, 13:00 Hrs [IST] RIVANNA, a d ...
The global Medtech Market size is set to witness a growth rate of 7% in the next 5 years. Rising volumes of surgical and ...
Global Veterinary Imaging Market OverviewThe global veterinary imaging market is experiencing steady expansion and is ...
March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial ...
ITWeb on MSN
Where AI actually belongs in enterprise systems
Where AI actually belongs in enterprise systemsIssued by BBDJohannesburg, 07 May 2026 AI in business is not a universal replacement for traditional software or automation. (Image: BBD) Artificial ...
According to MarketsandMarkets™, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to ...
Unlike traditional 3D tools that overwhelm users with endless menus and technical jargon, Tripo Studio uses advanced AI to ...
Rapid advancements in semiconductor technology and computational imaging are accelerating the adoption of light field technology worldwide. Manufacturers are developing compact, high-performance ...
Discover the key differences between Claude Co-work and OpenAI Codex, including pricing, integrations, and automation ...
According to MarketsandMarkets, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to USD 69.34 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results